Management & investors

Owners

CMC Contrast is owned by three well-known venture capital companies:

Malmöhus Invest AB, Øresund - Healthcare Capital KS, and Sunstone Capital A/S

Malmöhus Invest AB is one of Sweden’s most experienced venture capital companies, and Øresund - Healthcare Capital KS is a Danish venture capital company specialising in life science investments.

Sunstone Capital A/S is a Nordic venture capital investor based in Copenhagen. The firm focuses on developing and expanding early-stage technology and life science companies with strong potential to achieve global success in their markets.

Board of Directors

Magnus Corfitzen, Investment Director, Sunstone Capital, Chairman
Niels Mengel, CEO, Øresund -Healthcare Capital KS
Håkan Nelson, CEO, Malmöhus Invest AB
Per Foss, PhD, CEO, HUNT Biosciences AS
Bo Jesper Hansen, MD, CEO, Swedish Orphan AB

Management

Thomas Grönberg, Ph.D., Director Business Development
Jan Trøst Jørgensen, Ph.D., Director Medical Affairs

Subcontractors

Pharmaceutical development: Recipharm, Chemswed
Pre-clinical development: LabScantox
Clinical development: Trial Form Support
Regulatory management: DTA Consulting
Non-clinical pharmaceutical development: Peter McAnulty
Patent management: AWA Patent
Public relations: W Just W
Academic research: A number of internationally well-known university hospitals